A trial looking at pumitamig and ipilimumab for advanced liver cancer (ROSETTA HCC-206)

This trial is looking at 2 different doses of pumitamig with ipilimumab for liver cancer. It is also looking at how well pumitamig works on its own or with ipilimumab compared to standard treatment.

It is for people who:

• have a type of liver cancer called hepatocellular carcinoma

• have liver cancer that has spread or can’t be removed with surgery

• are having their first treatment for advanced liver cancer

You pronounce pumitamig as puh-mih-tah-mig.